Covington & Burling LLP
We only have limited information for this firm. Consider the following firms which have provided more information:
Peter Bogaert and Bart Van Vooren jointly lead the practice at Covington & Burling LLP, which leverages its international presence to act for a varied client base of trade associations and companies in the cosmetic and food, pharmaceuticals, and diagnostic spaces. The group is well versed in advising on reimbursement procedures, novel IVD regulations, and global pathogen sharing rules. Bogaert is known for his longstanding expertise in domestic and EU regulatory systems, frequently advising medical device and biotechnology companies on policy assignments. Van Vooren regularly appears before the General Court (EGC) and the Court of Justice of the European Union (CJEU), representing both human and veterinary pharmaceutical, and medical device companies.
Legal 500 Editorial commentary
Key clients
- AbbVie
- AstraZeneca
Abbreviated data is displayed for this firm.
Work highlights
- Representing Aloe Vera of Europe in litigation before the EU General Court, including a request for suspension, against a Commission Regulation banning HADs, a substance that is found naturally in most plants, for an infringement of the precautionary principle.
- Advising the vaccines working group of the IFPMA on matters involving seasonal influenza, as well as the Pandemic Influenza Preparedness Framework (PIP) under the umbrella of the WHO.
Abbreviated data is displayed for this firm.